9 results
8-K
EX-2.1
MACA
Moringa Acquisition Corp - Ordinary Shares
3 Apr 24
Entry into a Material Definitive Agreement
11:22am
proprietary AI/ML technologies that would enable skilled programmers to modify and debug such neural networks in the ordinary course.
(l) Except
8-K
EX-2.1
MACA
Moringa Acquisition Corp - Ordinary Shares
26 Feb 24
Silexion, a Clinical-Stage, Oncology-Focused Biotechnology Company, to Become Publicly Traded Via Business Combination with Moringa Acquisition Corp
5:29pm
enable skilled programmers to modify and debug such neural networks in the ordinary course.
(l) Except as set forth on Schedule 3.17(l) of the Company
10-K
go2pgeg 5i90aroqi6e
31 Mar 21
Annual report
5:15pm
424B4
op6cwe7pw2jlvvdqb
17 Feb 21
Prospectus supplement with pricing info
11:53am
S-1
1tg tmcq36x
1 Feb 21
IPO registration
4:12pm
DRS
r708ev kwi
22 Dec 20
Draft registration statement
12:00am
- Prev
- 1
- Next